Abstract

Necrotizing enterocolitis (NEC) is a devastating disease of premature infants with high mortality rate, indicating the need for precision treatment. NEC is characterized by intestinal inflammation and ischemia, as well derangements in intestinal microcirculation. Remote ischemic conditioning (RIC) has emerged as a promising tool in protecting distant organs against ischemia-induced damage. However, the effectiveness of RIC against NEC is unknown. To address this gap, we aimed to determine the efficacy and mechanism of action of RIC in experimental NEC. NEC was induced in mouse pups between postnatal day (P) 5 and 9. RIC was applied through intermittent occlusion of hind limb blood flow. RIC, when administered in the early stages of disease progression, decreases intestinal injury and prolongs survival. The mechanism of action of RIC involves increasing intestinal perfusion through vasodilation mediated by nitric oxide and hydrogen sulfide. RIC is a viable and non-invasive treatment strategy for NEC.

Necrotizing enterocolitis (NEC) is one of the most lethal gastrointestinal emergencies in neonates needing precision treatment. Here the authors show that remote ischemic conditioning is a non-invasive therapeutic method that enhances blood flow in the intestine, reduces damage, and improves NEC outcome.

Details

Title
Remote ischemic conditioning counteracts the intestinal damage of necrotizing enterocolitis by improving intestinal microcirculation
Author
Koike Yuhki 1 ; Li, Bo 2   VIAFID ORCID Logo  ; Ganji Niloofar 2 ; Zhu, Haitao 2 ; Miyake Hiromu 2 ; Chen, Yong 2 ; Lee, Carol 2 ; Janssen, Lok Maarten 2 ; Zozaya Carlos 3   VIAFID ORCID Logo  ; Lau, Ethan 2 ; Lee, Dorothy 2 ; Sinobol, Chusilp 2   VIAFID ORCID Logo  ; Zhang, Zhen 2 ; Yamoto Masaya 2 ; Wu, Richard Y 4 ; Inoue Mikihiro 5 ; Uchida Keiichi 5 ; Kusunoki Masato 5 ; Delgado-Olguin, Paul 6   VIAFID ORCID Logo  ; Mertens Luc 7 ; Daneman, Alan 8 ; Eaton, Simon 9   VIAFID ORCID Logo  ; Sherman, Philip M 10   VIAFID ORCID Logo  ; Pierro Agostino 11   VIAFID ORCID Logo 

 The Hospital for Sick Children, Translational Medicine Program, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); The Hospital for Sick Children, Division of General and Thoracic Surgery, Translational Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); Mie University Graduate School of Medicine, Departments of Gastrointestinal and Pediatric Surgery, Tsu, Japan (GRID:grid.260026.0) (ISNI:0000 0004 0372 555X) 
 The Hospital for Sick Children, Translational Medicine Program, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); The Hospital for Sick Children, Division of General and Thoracic Surgery, Translational Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646) 
 The Hospital for Sick Children, Division of Neonatology, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646) 
 Hospital for Sick Children, Cell Biology Program, Research Institute, Division of Gastroenterology, Hepatology and Nutrition, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Mie University Graduate School of Medicine, Departments of Gastrointestinal and Pediatric Surgery, Tsu, Japan (GRID:grid.260026.0) (ISNI:0000 0004 0372 555X) 
 The Hospital for Sick Children, Translational Medicine Program, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Molecular Genetics, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Heart & Stroke Richard Lewar Centre of Excellence, Toronto, Canada (GRID:grid.423576.1) 
 University of Toronto, The Labatt Family Heart Center, Cardiology, The Hospital for Sick Children, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 University of Toronto, Department of Diagnostic Imaging, Division of Nuclear Medicine, The Hospital for Sick Children, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 UCL Great Ormond Street Institute of Child Health, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
10  Hospital for Sick Children, Cell Biology Program, Research Institute, Division of Gastroenterology, Hepatology and Nutrition, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Faculty of Dentistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
11  The Hospital for Sick Children, Translational Medicine Program, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); The Hospital for Sick Children, Division of General and Thoracic Surgery, Translational Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Surgery, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2449451878
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.